These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12227916)

  • 1. Stone research on the bench: where we are and where we are going.
    Khan SR
    J Endourol; 2002 Aug; 16(6):413-6. PubMed ID: 12227916
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
    Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxalate binding proteins in calcium oxalate nephrolithiasis.
    Selvam R; Kalaiselvi P
    Urol Res; 2003 Aug; 31(4):242-56. PubMed ID: 12856168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
    Milliner D; Hoppe B; Groothoff J
    Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoxaluria, enzymuria and nephrolithiasis.
    Khan SR; Hackett RL
    Contrib Nephrol; 1993; 101():190-3. PubMed ID: 8467674
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxaluria and stone disease in the gastrointestinal bypass patient.
    Gregory JG
    Urol Clin North Am; 1981 Jun; 8(2):331-51. PubMed ID: 7268964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nephrolithiasis--the mechanism and progression of nephrolithiasis].
    Yasui T; Okada A; Itoh Y; Tozawa K; Kohri K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():618-22. PubMed ID: 16523965
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium oxalate monohydrate renal calculi. Formation and development mechanism.
    Söhnel O; Grases F
    Adv Colloid Interface Sci; 1995 Aug; 59():1-17. PubMed ID: 7576314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of dietary oxalate on kidney stone formation.
    Holmes RP; Assimos DG
    Urol Res; 2004 Oct; 32(5):311-6. PubMed ID: 15221245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperoxaluria.
    Cochat P; Rumsby G
    N Engl J Med; 2013 Aug; 369(7):649-58. PubMed ID: 23944302
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies using a porcine model: what insights into human calcium oxalate stone formation mechanisms has this model facilitated?
    Penniston KL; Patel SR; Schwahn DJ; Nakada SY
    Urolithiasis; 2017 Feb; 45(1):109-125. PubMed ID: 27904915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset of stone diseases and primary hyperoxaluria.
    Topaloglu R; Bakkaloglu A; Saatci U; Besbas N
    Paediatr Indones; 1990; 30(1-2):54-8. PubMed ID: 2284120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin and types of calcium oxalate monohydrate papillary renal calculi.
    Grases F; Costa-Bauzá A; Gomila I; Conte A
    Urology; 2010 Dec; 76(6):1339-45. PubMed ID: 20466410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual morphology of calcium oxalate calculi in primary hyperoxaluria.
    Daudon M; Estepa L; Lacour B; Jungers P
    J Nephrol; 1998; 11 Suppl 1():51-5. PubMed ID: 9604812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin and stone formation.
    Asakura H
    Int J Urol; 2002 Feb; 9(2):108; discussion 108-9. PubMed ID: 12028301
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Scheinman JI; Voziyan PA; Belmont JM; Chetyrkin SV; Kim D; Hudson BG
    Urol Res; 2005 Nov; 33(5):368-71. PubMed ID: 16292584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.